Slacker fails to mention:-13 Aug 2024 10:48
1. Raised £6m in May.
2. Genedrive® MT-RNR1 ID Kit (the one to do with potential hearing loss in babies now being marketed in France, Austria, Greece, Saudi Arabia, Turkey, and the Netherlands as well as the UK's NHS.
3. Breakthrough Device Designation from the U.S. Food and Drug Administration ("FDA") for the Genedrive® MT-RNR1 ID Kit. FDA approval applied for.
4. Genedrive PLC NICE recommends CYP2C19-ID Kit in final guidance, the one that helps decide the drug to use for people who have had a stroke. RNS just 2 weeks ago!!!
5. Obviously, they will also apply for FDA approval of the CYP2C19-ID Kit too. Easier now they have done the same procedure for the Genedrive® MT-RNR1 ID Kit!!! RNS to come.......?
6. Slacker is right - No institutional investors........YET. Cheek was CEO when the massively discounted placing was done. It upset shareholders massively. What about this. Maybe he was told that no investors will touch GDR while he is still there..........? Maybe that is why he went?
All IMHO.